Medicamen Biotech - MEDICAMEQ, 531146 corporate action history

Medicamen Biotech Ltd. NSE: MEDICAMEQ | BSE: 531146

Mid-range Performer

Download real time

390.25 -9.95 (-2.49%)

30.40% Fall from 52W High

24,305

NSE+BSE Volume

NSE 09 Jan, 2026 3:31 PM (IST)

Medicamen Biotech Bonus history

Medicamen Biotech has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Medicamen Biotech Split history

Medicamen Biotech has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Medicamen Biotech

Medicamen Biotech has declared 9 dividends since Sept. 21, 2010.

In the past 12 months, Medicamen Biotech has declared an equity dividend amounting to ₹1.00 per share.

At the current share price of ₹390.2500, Medicamen Biotech's dividend yield is 0.26%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep 2025	1.00	FINAL	19 Sep 2025	Equity Share
19 Sep 2024	1.00	FINAL	-	Equity Share
20 Sep 2023	1.00	FINAL	-	Equity Share
19 Sep 2022	1.00	FINAL	-	Equity Share
16 Sep 2021	1.00	FINAL	-	Equity Share
17 Sep 2020	0.50	FINAL	-	Equity Share
17 Sep 2019	1.00	FINAL	18 Sep 2019	Equity Share
08 Aug 2017	1.00	INTERIM	09 Aug 2017	Equity Share
21 Sep 2010	0.75	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Medicamen Biotech

The latest board meeting for Medicamen Biotech took place on 14 Nov 2025, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
14 Nov 2025	Quarterly Results	-
12 Aug 2025	Quarterly Results	-
30 May 2025	Audited Results & Final Dividend	-
26 Feb 2025	Preferential issue of shares	-
11 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
29 May 2024	Audited Results & Final Dividend	-
12 Feb 2024	Quarterly Results	-
10 Nov 2023	Quarterly Results	-

See all Board Meetings for Medicamen Biotech

Medicamen Biotech Rights history

Medicamen Biotech has not issued any rights since Jan 1, 2000.

See all Rights History for Medicamen Biotech

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%